Gilead gets a new approval for a drug.


Unfortunately retiring on easy street is more complicated than you think. Here's a road map.
The new technology of smartphones offers huge potential for entrepreneurs.
Advisers preach portfolio rebalancing as though it's investment gospel. But in practice, such preaching can be costly.